Single and Multiple Dose Evaluation of ABT-072 and to Evaluate the Effect of Food on the Pharmacokinetics of ABT-072
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
To assess the safety, tolerability and pharmacokinetics of the ABT-072 tablet formulation
administered as a single dose and then administered as multiple doses for 7 days. The effect
of food on the safety, tolerability and pharmacokinetics of the ABT-072 tablet will also be
evaluated.